67 related articles for article (PubMed ID: 15372482)
1. The clinical value of tumor burden at diagnosis in Hodgkin lymphoma.
Gobbi PG; Broglia C; Di Giulio G; Mantelli M; Anselmo P; Merli F; Zinzani PL; Rossi G; Callea V; Iannitto E; Paulli M; Garioni L; Ascari E
Cancer; 2004 Oct; 101(8):1824-34. PubMed ID: 15372482
[TBL] [Abstract][Full Text] [Related]
2. Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance.
Gobbi PG; Ghirardelli ML; Solcia M; Di Giulio G; Merli F; Tavecchia L; Bertè R; Davini O; Levis A; Broglia C; Maffè GC; Ilariucci F; Dore R; Ascari E
J Clin Oncol; 2001 Mar; 19(5):1388-94. PubMed ID: 11230483
[TBL] [Abstract][Full Text] [Related]
3. Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.
Gobbi PG; Bergonzi M; Bassi E; Merli F; Coriani C; Federico M
Hematol Oncol; 2013 Sep; 31(3):151-5. PubMed ID: 23108910
[TBL] [Abstract][Full Text] [Related]
4. Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters.
Gobbi PG; Bergonzi M; Bassi E; Merli F; Coriani C; Stelitano C; Iannitto E; Federico M
Oncol Rep; 2012 Sep; 28(3):815-20. PubMed ID: 22752083
[TBL] [Abstract][Full Text] [Related]
5. Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.
Gobbi PG; Valentino F; Bassi E; Coriani C; Merli F; Bonfante V; Marchianò A; Gallamini A; Bolis S; Stelitano C; Levis A; Federico M; Angrilli F; Di Giulio G; Corazza GR
Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):396-402. PubMed ID: 21729691
[TBL] [Abstract][Full Text] [Related]
6. Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.
Gobbi PG; Bassi E; Bergonzi M; Merli F; Coriani C; Iannitto E; Luminari S; Polimeno G; Federico M
Hematol Oncol; 2012 Dec; 30(4):194-9. PubMed ID: 22271092
[TBL] [Abstract][Full Text] [Related]
7. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV].
Riedinger JM; Barillot I; Coudert B; Fargeot P; Berriolo-Riedinger A; Guerrin J
Bull Cancer; 1996 Aug; 83(8):654-63. PubMed ID: 8869046
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
15. [Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Tarasenkova AA; Filatova LV; Gershanovich ML; Semiglazova TIu
Vopr Onkol; 2012; 58(1):101-9. PubMed ID: 22629838
[TBL] [Abstract][Full Text] [Related]
16. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
17. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
[TBL] [Abstract][Full Text] [Related]
18. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of biological markers in paediatric Hodgkin lymphoma.
Farruggia P; Puccio G; Sala A; Todesco A; Buffardi S; Garaventa A; Bottigliero G; Bianchi M; Zecca M; Locatelli F; Pession A; Pillon M; Favre C; D'Amico S; Provenzi M; Trizzino A; Zanazzo GA; Sau A; Santoro N; Murgia G; Casini T; Mascarin M; Burnelli R;
Eur J Cancer; 2016 Jan; 52():33-40. PubMed ID: 26630532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
